Core Laboratories N.V. (NYSE:CLB) had its price objective decreased by stock analysts at Royal Bank Of Canada from $115.00 to $112.00 in a research note issued on Thursday, Marketbeat.com reports. The brokerage presently has an “outperform” rating on the oil and gas company’s stock. Royal Bank Of Canada’s target price indicates a potential upside of 23.00% from the stock’s current price.

A number of other brokerages have also recently weighed in on CLB. Piper Jaffray Companies set a $97.00 target price on shares of Core Laboratories N.V. and gave the stock a “hold” rating in a report on Wednesday, July 26th. ValuEngine upgraded shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a report on Friday, August 4th. Citigroup Inc. reduced their target price on shares of Core Laboratories N.V. from $102.00 to $100.00 and set a “neutral” rating for the company in a report on Wednesday, July 26th. Zacks Investment Research cut shares of Core Laboratories N.V. from a “buy” rating to a “hold” rating in a report on Friday, June 23rd. Finally, BidaskClub upgraded shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a report on Tuesday, June 13th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $113.58.

Shares of Core Laboratories N.V. (NYSE CLB) traded up 0.08% on Thursday, reaching $91.13. 266,414 shares of the company were exchanged. Core Laboratories N.V. has a 12 month low of $86.55 and a 12 month high of $125.83. The company’s 50-day moving average price is $95.23 and its 200 day moving average price is $105.22. The company has a market cap of $4.02 billion, a price-to-earnings ratio of 55.91 and a beta of 1.60.

Core Laboratories N.V. (NYSE:CLB) last issued its earnings results on Monday, July 24th. The oil and gas company reported $0.52 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.51 by $0.01. The firm had revenue of $163.90 million during the quarter, compared to analysts’ expectations of $168.23 million. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The firm’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same period last year, the firm posted $0.35 earnings per share. On average, equities research analysts expect that Core Laboratories N.V. will post $2.04 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Core Laboratories N.V. (CLB) PT Lowered to $112.00 at Royal Bank Of Canada” was first posted by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/09/07/core-laboratories-n-v-clb-pt-lowered-to-112-00-at-royal-bank-of-canada.html.

Institutional investors have recently bought and sold shares of the stock. Goldman Sachs Group Inc. boosted its stake in Core Laboratories N.V. by 156.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 68,823 shares of the oil and gas company’s stock worth $7,951,000 after purchasing an additional 41,955 shares during the period. Parsons Capital Management Inc. RI boosted its stake in Core Laboratories N.V. by 15.4% in the 1st quarter. Parsons Capital Management Inc. RI now owns 10,436 shares of the oil and gas company’s stock worth $1,206,000 after purchasing an additional 1,394 shares during the period. Morgan Stanley boosted its stake in Core Laboratories N.V. by 17.5% in the 1st quarter. Morgan Stanley now owns 167,465 shares of the oil and gas company’s stock worth $19,346,000 after purchasing an additional 24,929 shares during the period. Comerica Securities Inc. boosted its stake in Core Laboratories N.V. by 22.5% in the 1st quarter. Comerica Securities Inc. now owns 2,529 shares of the oil and gas company’s stock worth $292,000 after purchasing an additional 465 shares during the period. Finally, Cue Financial Group Inc. boosted its stake in Core Laboratories N.V. by 11.0% in the 2nd quarter. Cue Financial Group Inc. now owns 2,525 shares of the oil and gas company’s stock worth $256,000 after purchasing an additional 250 shares during the period.

About Core Laboratories N.V.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Analyst Recommendations for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.